- Home
- GPRO vs CERT Comparison
GPRO vs CERT Comparison
Compare GPRO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPRO | CERT |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.4M | 1.4B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GPRO | CERT |
|---|---|---|
| Price | $1.61 | $9.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $13.25 |
| AVG Volume (30 Days) | ★ 3.2M | 2.3M |
| Earning Date | 02-05-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $650,751,000.00 | $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $12.41 | $6.77 |
| P/E Ratio | ★ N/A | $131.28 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $0.40 | $8.03 |
| 52 Week High | $3.05 | $15.69 |
Technical Indicators
Market Signals| Indicator | GPRO | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 47.95 |
| Support Level | $1.50 | $8.42 |
| Resistance Level | $1.92 | $9.17 |
| Average True Range (ATR) | 0.11 | 0.39 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 25.08 | 53.60 |
Price Performance
Historical ComparisonAbout GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.